BEAT: HeartBeam, Inc. Stock

by  •  • Comments Off on BEAT: HeartBeam, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 51.89
Enterprise Value ($M) 35.70
Book Value ($M) 15.94
Book Value / Share 0.60
Price / Book 3.26
NCAV ($M) 15.63
NCAV / Share 0.59
Price / NCAV 3.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.92
Return on Assets (ROA) -10.02
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 14.09
Current Ratio 14.09

Balance Sheet (mrq) ($M)
Current Assets 16.82
Assets 17.13
Liabilities 1.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.31
Net Income -14.64

Cash Flow Statement (mra) ($M)
Cash From Operations -12.09
Cash from Investing -0.26
Cash from Financing 24.99

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-25 13D Strome Mark E 12.00
08-28 13D Public Ventures, Llc 9.41
06-02 13D Schwartzberg Andrew 7.33

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 3,674 22,274 16.49
2024-04-24 5,594 2,039 274.35
2024-04-23 2,875 6,250 46.00
2024-04-22 14,000 5,751 243.44

(click for more detail)

Similar Companies
AVGR – Avinger, Inc. AXGN – AxoGen, Inc.
BBLG – Bone Biologics Corporation BIOL – BIOLASE, Inc.
BJDX – Bluejay Diagnostics, Inc.


Financial data and stock pages provided by
Fintel.io